Cantoni Therapeutics closed a funding round (amount undisclosed) in Sep 2025. The company is based in Leiden, Netherlands. Investors in the round: Brabantse Ontwikkelings Maatschappij (BOM), Libertatis Ergo Holding BV (LEH). Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
